PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LTRN vs. TALK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between LTRN and TALK is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

LTRN vs. TALK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lantern Pharma Inc. (LTRN) and Talkspace, Inc. (TALK). The values are adjusted to include any dividend payments, if applicable.

-75.00%-70.00%-65.00%-60.00%-55.00%NovemberDecember2025FebruaryMarchApril
-77.00%
-73.76%
LTRN
TALK

Key characteristics

Sharpe Ratio

LTRN:

-0.70

TALK:

-0.44

Sortino Ratio

LTRN:

-1.00

TALK:

-0.29

Omega Ratio

LTRN:

0.90

TALK:

0.97

Calmar Ratio

LTRN:

-0.70

TALK:

-0.31

Martin Ratio

LTRN:

-1.32

TALK:

-0.83

Ulcer Index

LTRN:

46.34%

TALK:

32.70%

Daily Std Dev

LTRN:

87.01%

TALK:

61.72%

Max Drawdown

LTRN:

-88.69%

TALK:

-95.17%

Current Drawdown

LTRN:

-87.18%

TALK:

-78.10%

Fundamentals

Market Cap

LTRN:

$32.25M

TALK:

$442.99M

EPS

LTRN:

-$1.93

TALK:

$0.01

Total Revenue (TTM)

LTRN:

$0.00

TALK:

$142.18M

Gross Profit (TTM)

LTRN:

-$46.27K

TALK:

$64.11M

EBITDA (TTM)

LTRN:

-$16.48M

TALK:

-$2.82M

Returns By Period

In the year-to-date period, LTRN achieves a -11.91% return, which is significantly higher than TALK's -14.24% return.


LTRN

YTD

-11.91%

1M

-23.22%

6M

-24.66%

1Y

-63.79%

5Y*

N/A

10Y*

N/A

TALK

YTD

-14.24%

1M

-8.93%

6M

12.77%

1Y

-27.40%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

LTRN vs. TALK — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LTRN
The Risk-Adjusted Performance Rank of LTRN is 2020
Overall Rank
The Sharpe Ratio Rank of LTRN is 2020
Sharpe Ratio Rank
The Sortino Ratio Rank of LTRN is 1919
Sortino Ratio Rank
The Omega Ratio Rank of LTRN is 2424
Omega Ratio Rank
The Calmar Ratio Rank of LTRN is 1313
Calmar Ratio Rank
The Martin Ratio Rank of LTRN is 2424
Martin Ratio Rank

TALK
The Risk-Adjusted Performance Rank of TALK is 3838
Overall Rank
The Sharpe Ratio Rank of TALK is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of TALK is 3737
Sortino Ratio Rank
The Omega Ratio Rank of TALK is 3838
Omega Ratio Rank
The Calmar Ratio Rank of TALK is 4040
Calmar Ratio Rank
The Martin Ratio Rank of TALK is 4343
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LTRN vs. TALK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Lantern Pharma Inc. (LTRN) and Talkspace, Inc. (TALK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for LTRN, currently valued at -0.70, compared to the broader market-2.00-1.000.001.002.00
LTRN: -0.70
TALK: -0.44
The chart of Sortino ratio for LTRN, currently valued at -1.00, compared to the broader market-6.00-4.00-2.000.002.004.00
LTRN: -1.00
TALK: -0.29
The chart of Omega ratio for LTRN, currently valued at 0.90, compared to the broader market0.501.001.502.00
LTRN: 0.90
TALK: 0.97
The chart of Calmar ratio for LTRN, currently valued at -0.70, compared to the broader market0.001.002.003.004.00
LTRN: -0.70
TALK: -0.31
The chart of Martin ratio for LTRN, currently valued at -1.32, compared to the broader market-10.00-5.000.005.0010.0015.00
LTRN: -1.32
TALK: -0.83

The current LTRN Sharpe Ratio is -0.70, which is lower than the TALK Sharpe Ratio of -0.44. The chart below compares the historical Sharpe Ratios of LTRN and TALK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
-0.70
-0.44
LTRN
TALK

Dividends

LTRN vs. TALK - Dividend Comparison

Neither LTRN nor TALK has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

LTRN vs. TALK - Drawdown Comparison

The maximum LTRN drawdown since its inception was -88.69%, smaller than the maximum TALK drawdown of -95.17%. Use the drawdown chart below to compare losses from any high point for LTRN and TALK. For additional features, visit the drawdowns tool.


-85.00%-80.00%-75.00%-70.00%-65.00%NovemberDecember2025FebruaryMarchApril
-87.18%
-78.10%
LTRN
TALK

Volatility

LTRN vs. TALK - Volatility Comparison

Lantern Pharma Inc. (LTRN) has a higher volatility of 19.12% compared to Talkspace, Inc. (TALK) at 14.46%. This indicates that LTRN's price experiences larger fluctuations and is considered to be riskier than TALK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%40.00%45.00%NovemberDecember2025FebruaryMarchApril
19.12%
14.46%
LTRN
TALK

Financials

LTRN vs. TALK - Financials Comparison

This section allows you to compare key financial metrics between Lantern Pharma Inc. and Talkspace, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab